|
1
|
Parkin DM, Pisani P and Ferlay J: Global
cancer statistics. CA Cancer J Clin. 49:33–64. 1999. View Article : Google Scholar
|
|
2
|
Kurokawa Y, Matoba R, Takemasa I, et al:
Molecular-based prediction of early recurrence in hepatocellular
carcinoma. J Hepatol. 41:284–291. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lai EC, Fan ST, Lo CM, Chu KM, Liu CL and
Wong J: Hepatic resection for hepatocellular carcinoma. An audit of
343 patients Ann Surg. 221:291–298. 1995.PubMed/NCBI
|
|
4
|
Ono T, Yamanoi A, Nazmy El Assal O, Kohno
H and Nagasue N: Adjuvant chemotherapy after resection of
hepatocellular carcinoma causes deterioration of long-term
prognosis in cirrhotic patients: metaanalysis of three randomized
controlled trials. Cancer. 91:2378–2385. 2001. View Article : Google Scholar
|
|
5
|
Genda T, Sakamoto M, Ichida T, Asakura H,
Kojiro M, Narumiya S and Hirohashi S: Cell motility mediated by rho
and Rho-associated protein kinase plays a critical role in
intrahepatic metastasis of human hepatocellular carcinoma.
Hepatology. 30:1027–1036. 1999. View Article : Google Scholar
|
|
6
|
Ye QH, Qin LX, Forgues M, et al:
Predicting hepatitis B virus-positive metastatic hepatocellular
carcinomas using gene expression profiling and supervised machine
learning. Nat Med. 9:416–423. 2003. View
Article : Google Scholar
|
|
7
|
Qin LX and Tang ZY: Recent progress in
predictive biomarkers for metastatic recurrence of human
hepatocellular carcinoma: a review of the literature. J Cancer Res
Clin Oncol. 130:497–513. 2004.PubMed/NCBI
|
|
8
|
Fidler IJ: The organ microenvironment and
cancer metastasis. Differentiation. 70:498–505. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fidler IJ, Kim SJ and Langley RR: The role
of the organ microenvironment in the biology and therapy of cancer
metastasis. J Cell Biochem. 101:927–936. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leek RD, Harris AL and Lewis CE: Cytokine
networks in solid human tumors: regulation of angiogenesis. J
Leukoc Biol. 56:423–435. 1994.PubMed/NCBI
|
|
11
|
Giannelli G, Fransvea E, Marinosci F, et
al: Transforming growth factor-beta1 triggers hepatocellular
carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol.
161:183–193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iyer S, Wang ZG, Akhtari M, Zhao W and
Seth P: Targeting TGFbeta signaling for cancer therapy. Cancer Biol
Ther. 4:261–266. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oft M, Peli J, Rudaz C, Schwarz H, Beug H
and Reichmann E: TGFbeta1 and Ha-Ras collaborate in modulating the
phenotypic plasticity and invasiveness of epithelial tumor cells.
Genes Dev. 10:2462–2477. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stover DG, Bierie B and Moses HL: A
delicate balance: TGF-beta and the tumor microenvironment. J Cell
Biochem. 101:851–861. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song BC, Chung YH, Kim JA, et al:
Transforming growth factor-beta1 as a useful serologic marker of
small hepatocellular carcinoma. Cancer. 94:175–180. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katabami K, Mizuno H, Sano R, et al:
Transforming growth factor-beta1 upregulates transcription of
alpha3 integrin gene in hepatocellular carcinoma cells via
Ets-transcription factor-binding motif in the promoter region. Clin
Exp Metastasis. 22:539–548. 2005. View Article : Google Scholar
|
|
17
|
Lin JK and Chou CK: In vitro apoptosis in
the human hepatoma cell line induced by transforming growth factor
beta 1. Cancer Res. 52:385–388. 1992.PubMed/NCBI
|
|
18
|
Li Y, Tang Y, Ye L, et al: Establishment
of a hepatocellular carcinoma cell line with unique metastatic
characteristics through in vivo selection and screening for
metastasis-related genes through cDNA microarray. J Cancer Res Clin
Oncol. 129:43–51. 2003.
|
|
19
|
Li Y, Tang ZY, Ye SL, et al: Establishment
of cell clones with different metastatic potential from the
metastatic hepatocellular carcinoma cell line MHCC97. World J
Gastroenterol. 7:630–636. 2001.PubMed/NCBI
|
|
20
|
Zhou J, Tang ZY, Fan J, et al:
Capecitabine inhibits postoperative recurrence and metastasis after
liver cancer resection in nude mice with relation to the expression
of platelet-derived endothelial cell growth factor. Clin Cancer
Res. 9:6030–6037. 2003.
|
|
21
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889 Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
|
22
|
Singh RK, Bucana CD, Gutman M, Fan D,
Wilson MR and Fidler IJ: Organ site-dependent expression of basic
fibroblast growth factor in human renal cell carcinoma cells. Am J
Pathol. 145:365–374. 1994.PubMed/NCBI
|
|
23
|
Takahashi Y, Mai M, Wilson MR, Kitadai Y,
Bucana C and Ellis L: Site-dependent expression of vascular
endothelial growth factor, angiogenesis and proliferation in human
gastric carcinoma. Int J Oncol. 8:701–705. 1996.PubMed/NCBI
|
|
24
|
Welm AL: TGFbeta primes breast tumor cells
for metastasis. Cell. 133:27–28. 2008. View Article : Google Scholar
|
|
25
|
Itoh S, Itoh F, Goumans MJ and Ten Dijke
P: Signaling of transforming growth factor-b family members through
Smad proteins. Eur J Biochem. 267:6954–6967. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwak HJ, Park MJ, Cho H, et al:
Transforming growth factor-beta1 induces tissue inhibitor of
metalloproteinase-1 expression via activation of extracellular
signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol
Cancer Res. 4:209–220. 2006. View Article : Google Scholar
|
|
27
|
Watanabe H, de Caestecker MP and Yamada Y:
Transcriptional cross-talk between Smad, ERK1/2, and p38
mitogen-activated protein kinase pathways regulates transforming
growth factor-beta-induced aggrecan gene expression in chondrogenic
ATDC5 cells. J Biol Chem. 276:14466–14473. 2001.
|
|
28
|
Kaplan RN, Riba RD, Zacharoulis S, et al:
VEGFR1-positive haematopoietic bone marrow progenitors initiate the
pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar
|
|
29
|
Loberg RD, Bradley DA, Tomlins SA,
Chinnaiyan AM and Pienta KJ: The lethal phenotype of cancer: the
molecular basis of death due to malignancy. CA Cancer J Clin.
57:225–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
